Blog

According to a study published in the American Journal of Managed Care integrating mental health care access into a comprehensive care plan improves the likelihood of medication adherence among people living with HIV. The study, conducted in 2018, utilized a cross-sectional survey to identify needs among people living with HIV in the Midwestern region of the United States and distinguished…

Thursday, August 20, marks Southern HIV/AIDS Awareness Day (SHAAD) 2020. Launched last year by the Southern AIDS Coalition, the day presents an opportunity to draw attention to the epidemic in the South, which comprises 51% of new HIV diagnoses annually, although only 38% of the U.S. population lives there.  The Centers for Disease Control and Prevention (CDC) defines the South…

Life can sometimes feel like an endless series of highs and lows, and we hardly notice how each one propels us from one moment to the next. While the thrill of achievement is fleeting at best, the fallout from a mistake can sometimes seem like an endless free fall. When it comes to HIV, those who live with the virus…

The U.S. Food and Drug Administration approved a new drug that combats drug resistance among "heavily treatment-experienced" HIV-positive people, drugmaker ViiV Healthcare announced Thursday. The medication, called fostemsavir and marketed under the name Rukobia, is to be used in combination with other antiretroviral medications and will specifically address those whose regimens are not succeeding because of resistance, intolerance, or safety considerations. “There is…